Connect Biopharma HldgsCNTB
13F holders, Q1 2024 (March 31)12holders
1famous investor
$1.74avg. 13F price*
At the end of Q1 2024, 12 institutions reported holding Connect Biopharma Hldgs Ltd. (CNTB) in their 13F filings. The largest holders were BML Capital Management, LLC ($3.6M), BlackRock Inc. ($1.8M) and OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ($889K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Connect Biopharma Hldgs Ltd.
- CUSIP
- 207523101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $35K |
| Exits | 4 | $3.6M |
Ownership 12 holders
| BML Capital Management, LLC | 2.40% | Reduce 0.0% | 2,061,338 | $3.6M |
| BlackRock Inc. | 0.00% | No change | 1,040,067 | $1.8M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.03% | Reduce -9.0% | 510,701 | $889K |
| Renaissance Technologies | 0.00% | Reduce -19.5% | 239,900 | $417K |
| Geode Capital Management, LLC | 0.00% | No change | 27,961 | $49K |
| Commonwealth Equity Services, LLC | 0.00% | New | 20,000 | $35K |
| Keudell/Morrison Wealth Management | 0.01% | Add +75.9% | 19,700 | $34K |
| Rhumbline Advisers | 0.00% | No change | 16,520 | $29K |
| Two Sigma Investments, LP | 0.00% | Reduce -5.3% | 10,805 | $19K |
| JPMorgan Chase & Co. | 0.00% | No change | 121 | $211 |
| Qube Research & Technologies Ltd | 0.00% | No change | 46 | $80 |
| Simplex Trading, LLC | 0.00% | New | 81 | $0 |
"% of holder's portfolio" is CNTB's weight in each manager's 13F, not the share of Connect Biopharma Hldgs Ltd. the manager owns.